Aldosterone and large artery vessels [1]

Hypertension

Volumn 47, Issue 6, 2006, Pages

  Epstein, Murray ^a   Safar, Michel E ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; EPLERENONE; MESSENGER RNA;

BLOOD VESSEL; CAROTID ARTERY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DOSE RESPONSE; GENOTYPE; HUMAN; HYPERTENSION; LETTER; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; VASCULARIZATION; ANIMAL; ARTERY; ELASTICITY; NOTE; PHYSIOLOGY;

ALDOSTERONE; ANIMALS; ARTERIES; ELASTICITY; HUMANS;

EID: 33744991091     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000218856.75376.97     Document Type: Letter

References (5)

1. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension. 2006;47:312-318.
2. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats - effects of eplerenone. Circulation. 2002;106:2848-2853.
3. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1997;17:1152-1156.
4. Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, Safar ME. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens. 1997;10:1326-1334.
5. Safar ME, Cattan V, Lacolley P, Nzietchueng R, Labat C, Lajemi M, de Luca N, Benetos A. Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension. J Hypertens. 2005;23:1159-1166.